Literature DB >> 26076865

[Single or double moral standards? Professional ethics of psychiatrists regarding self-determination, rights of third parties and involuntary treatment].

T Pollmächer1.   

Abstract

The current intensive discussion on the legal and moral aspects of involuntary treatment of psychiatric patients raises a number of ethical issues. Physicians are unambiguously obligated to protect patient welfare and autonomy; however, in psychiatric patients disease-related restrictions in the capacity of self-determination and behaviors endangering the rights of third parties can seriously challenge this unambiguity. Therefore, psychiatry is assumed to have a double function and is also obligated to third parties and to society in general. Acceptance of such a kind of double obligation carries the risk of double moral standards, placing the psychiatrist ethically outside the community of physicians and questioning the unrestricted obligation towards the patient. The present article formulates a moral position, which places the psychiatrist, like all other physicians, exclusively on the side of the patient in terms of professional ethics and discusses the practical problems arising from this moral position.

Entities:  

Mesh:

Year:  2015        PMID: 26076865     DOI: 10.1007/s00115-015-4303-z

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  6 in total

1.  [Social control function of psychiatry--contra].

Authors:  Thomas Pollmächer
Journal:  Psychiatr Prax       Date:  2013-09-05

2.  [Social control function of psychiatry--pro].

Authors:  Tilman Steinert
Journal:  Psychiatr Prax       Date:  2013-09-05

3.  [Compulsory treatment in psychiatry: an ethical analysis of the new legal regulations for clinical practice].

Authors:  J Vollmann
Journal:  Nervenarzt       Date:  2014-05       Impact factor: 1.214

4.  [Psychiatry caught between emergency response and therapy: compulsory treatment following the jurisprudence of the federal constitutional court and the federal supreme court].

Authors:  Jürgen L Müller; Peter Falkai; Frank Schneider; Iris Hauth; Wolfgang Maier
Journal:  Psychiatr Prax       Date:  2013-10-07

5.  [Legal regulation of coercion in psychiatry--a task for the professional association?].

Authors:  Martin Zinkler
Journal:  Psychiatr Prax       Date:  2013-04-04

6.  [Respect for self-determination and use of coercion in the treatment of mentally ill persons: an ethical position statement of the DGPPN].

Authors: 
Journal:  Nervenarzt       Date:  2014-11       Impact factor: 1.214

  6 in total
  5 in total

1.  [Coercive measures in German hospitals for psychiatry and psychotherapy : A pilot study by the DGPPN to evaluate a uniform assessment instrument].

Authors:  K Adorjan; T Steinert; E Flammer; A Deister; M Koller; M Zinkler; S C Herpertz; S Häfner; F Hohl-Radke; K H Beine; P Falkai; G Gerlinger; O Pogarell; T Pollmächer
Journal:  Nervenarzt       Date:  2017-07       Impact factor: 1.214

Review 2.  [Autonomy focusing as guiding idea of minimally restrictive psychiatry].

Authors:  Thomas Pollmächer
Journal:  Nervenarzt       Date:  2019-07       Impact factor: 1.214

3.  [Core principles for the regulation of placement subject to public law in psychiatric hospitals - with explanations].

Authors: 
Journal:  Nervenarzt       Date:  2016-03       Impact factor: 1.214

Review 4.  [Psychiatry as a practical science : Considerations following Wolfgang Wieland (1933-2015)].

Authors:  M Jäger; M E Wigand; T Becker
Journal:  Nervenarzt       Date:  2017-01       Impact factor: 1.214

5.  Preventing and Reducing Coercive Measures-An Evaluation of the Implementation of the Safewards Model in Two Locked Wards in Germany.

Authors:  Johanna Baumgardt; Dorothea Jäckel; Heike Helber-Böhlen; Nicole Stiehm; Karin Morgenstern; Andre Voigt; Enrico Schöppe; Ann-Kathrin Mc Cutcheon; Edwin Emilio Velasquez Lecca; Michael Löhr; Michael Schulz; Andreas Bechdolf; Stefan Weinmann
Journal:  Front Psychiatry       Date:  2019-05-24       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.